Real-life results from the prospective QoliXane trial of the platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry.

Salah-Eddin Al-Batran,Ralf Hofheinz,Alexander Reichart,Claudia Pauligk,Rudolf Schlag,Gabriele Margareta Siegler,Heinz-Gert Hoeffkes,Wolfgang Blau,Nils Homann,Jörg Trojan,Oliver Waidmann,Daniel Pink,Helmut Messmann,Volker Kunzmann,Arndt Vogel,Thomas Jens Ettrich,Caroline Schoenherr,Marina Schaaf,Gerrit zur Hausen,Thorsten Oliver Goetze

Real-life results from the prospective QoliXane trial of the platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry.

2020

4625Background: Gemcitabine and nab-paclitaxel (NPG) is standard first-line therapy for metastatic pancreatic cancer (mPC), but the pivotal study did not include quality of life (QoL) analyses. Met...

Keywords:

Physical therapy
Oncology
Quality of life
Internal medicine
Pancreatic cancer
Medicine
Translational research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations